Entering text into the input field will update the search result below

Cabaletta Bio stock soars premarket on fast track designation for MuSK-CAART

Mar. 01, 2022 8:57 AM ETCABABy: Jessica Kuruthukulangara, SA News Editor2 Comments
  • Cabaletta Bio (NASDAQ:CABA) stock jumped 11% premarket after the U.S. FDA granted Fast Track Designation for MuSK-CAART, or muscle-specific kinase (MuSK) chimeric autoantibody receptor T (MuSK-CAART) cells, to improve muscle strength in patients with MuSK antibody-positive myasthenia gravis.
  • MuSK-CAART is

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.